By Fraiser Kansteiner
Six drugmakers working on COVID-19 antibody treatments want to swap information and scale up production before those therapies win approval—and now they have Justice Department approval to share their need-to-know secrets.
read more
By Robert King
A new report from PwC found that deal activity declined in the first half of the year in the health services industry due in part to the COVID-19 pandemic.
read more
By Angus Liu
Researchers at Columbia University have isolated a cocktail of antibodies from COVID-19 patients they say could offer a new and potentially potent option for treating and preventing the disease. Some of the antibodies target areas of SARS-CoV-2 that are not addressed by drugs currently in development, they said.
read more
By Kyle Blankenship
Maryland biotech Novavax scored a big leg up in its hunt for a COVID-19 vaccine with a major infusion from the Trump administration this month. Now, Novavax is using some of those funds to help supply doses for a pivotal late-stage trial down the road.
read more
By Heather Landi
Two New York City-metro health systems are collaborating with Nanowear to research the use of a sensor-embedded undergarment to monitor COVID-19 patients. Find out why Meridian Health Systems and Maimonides Medical Center see the startup's technology as a promising tool to aid in COVID-19 diagnosis.
read more
By Conor Hale
Despite its first overall quarterly sales decline in nearly a decade—dragged down by the global spread of COVID-19, as well as biosimilars encroaching on three of its top-selling cancer drugs—the pandemic has still been a boost for Roche’s diagnostics division.
read more
By Angus Liu
CanSino Biolgocis' adenovirus-vectored COVID-19 vaccine induced antibody and T-cell responses in mid-phase trial. AstraZeneca signs COVID-19 vaccine production deal with SK Bioscience. U.S. accuses two Chinese hackers of targeting COVID-19-related researches. And more.
read more
By Paige Minemyer
Cigna is moving full speed ahead with significant expansion in the Medicare Advantage market and has tapped a new exec to spearhead that effort.
read more
By Eric Sagonowsky, Angus Liu, Kyle Blankenship, Conor Hale, Fraiser Kansteiner
Demand for coronavirus testing saw Roche's diagnostic sales rise. States and major pharmacy chains are seeking testing alternatives as labs like Quest and LabCorp struggle to process results quickly. And researchers created a version of the virus' spike protein that could speed up vaccine production. Plus, Fauci thinks schools should reopen on a regional basis.
read more
By Healthcare Staff
Follow along with the latest COVID-19 news straight from the Fierce Healthcare team.
read more
